Zobrazeno 1 - 10
of 14
pro vyhledávání: '"I. T. Abesadze"'
Autor:
T. F. Subbotina, Yu. A. Kudaev, N. L. Lokhovinina, M. Z. Alugishvili, I. T. Abesadze, I. V. Titenkov, M. A. Chernyavskiy, A. V. Panov, A. A. Zhloba
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 13, Iss 4, Pp 540-548 (2023)
Scientific relevance. A key anti-ischaemic mechanism of some medicinal products involves their effects on the metabolism of endothelial vasodilators, particularly the synthesis of nitric oxide from arginine and its precursor citrulline.Aim. The study
Externí odkaz:
https://doaj.org/article/24e0d3e6c68d47f49da23db31352c51c
Autor:
Yu. A. Kudaev, A. V. Vorobeva, N. L. Lokhovinina, I. T. Abesadze, M. Z. Alugishvili, I. V. Titenkov, M. A. Chernyavsky, A. V. Panov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 5, Pp 444-451 (2023)
Aim. To assess the prevalence of ischemic myocardial injury and the cardioprotective effect of nicorandil by assessing high-sensitivity cardiac troponin (hs-cTn) in patients with stable coronary artery disease (CAD) during elective lower limb surgery
Externí odkaz:
https://doaj.org/article/8d027ec1cfcf4f4aabb50987f7578623
Autor:
A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 3, Pp 301-308 (2017)
Aim. To assess the safety of the application of high-dose atorvastatin and its effect on metabolic parameters, such as the total level of nitric oxide and homocysteine in the blood plasma in patients with ischemic heart disease during a coronary arte
Externí odkaz:
https://doaj.org/article/1bfcdcc04a824df486f52f9099c6f55c
Autor:
Yu. A. Kudaev, M. A. Chernyavsky, D. V. Chuev, A. V. Chernov, N. L. Lokhovinina, I. T. Abesadze, M. Z. Alugishvili, E. V. Kuleshova, A. V. Panov
Publikováno v:
Translational Medicine. 8:15-23
Background. Until now, the issue of surgical treatment staging in patients with aortic pathology coexisting with coronary artery disease and atherosclerosis of the peripheral arteries remains controversial because of features of each clinical situati
Autor:
M. Z. Alugishvili, N. L. Lokhovinina, O.S. Melnichnikova, T.V. Vavilova, I.A. Nazarova, A. V. Panov, O.V. Sirotkina, I. T. Abesadze
Publikováno v:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 16:60-65
Despite the fact that acetylsalicylic acid (ASA) is the "gold" standard for the prevention of cardiovascular complications in patients with coronary heart disease (CAD), a number of patients still have risks of atherothrombosis. In the present study,
Autor:
M. A. Chernyavsky, Yu. A. Kudaev, M. Z. Alugishvili, E. V. Kuleshova, I. T. Abesadze, A. V. Panov, N. L. Lokhovinina
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 27:415-426
Background. Atherosclerotic disease of the arteries of the lower extremities or peripheral arterial disease (PAD) affects both men and women. PAD can be combined with the damage of other vascular regions, which is defined as multifocal atherosclerosi
Autor:
Yu. A. Kudaev, I. V. Titenkov, M. Z. Alugishvili, N. L. Lokhovinina, I. T. Abesadze, E. V. Kuleshova, A. V. Panov
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 26:629-639
The incidence of cardiovascular complications in non-cardiac surgery is about 3 %. The review presents the data on the assessment of cardiovascular risk (CVR) in non-cardiac surgery. The algorithm of decisionmaking considers the functional state of t
Autor:
K. V. Korzhenevskaya, M. L. Gordeev, I. T. Abesadze, I. V. Suhova, M. V. Solovyova, A. A. Zhloba, E. S. Alekseevskaya, N. L. Lohovinina, L. V. Mihaylova, T. F. Subbotina, M. I. Buthashvili, M. Z. Alugishvili, A. V. Panov
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 13, Iss 3, Pp 301-308 (2017)
Aim . To assess the safety of the application of high-dose atorvastatin and its effect on metabolic parameters, such as the total level of nitric oxide and homocysteine in the blood plasma in patients with ischemic heart disease during a coronary art
Autor:
A V, Panov, M Z, Alugishvili, I T, Abesadze, N L, Lokhovinina, K V, Korzhenewskaya, I V, Titenkov, E V, Kuleshov, D V, Duplyakov, S M, Hohlunov, A V, Kryukov, R A, Libis, E N, Isayeva, I R, Basyrova, D V, Safonova
Publikováno v:
Kardiologiia. 55(6)
Literature data and results of our own register have indicate that hypertension is one of the most common risk factor in patients with ischemic heart disease (IHD) who have undergone coronary artery bypass grafting (CABG). But despite proven benefits
Autor:
L.B. Mitrofanova, N. L. Lohovinina, M. I. Buthashvili, M. Z. Alugishvili, M. L. Gordeev, E V Kuleshov, K. V. Korzhenevskaya, A. V. Panov, I. T. Abesadze
Publikováno v:
Kardiologiia. 56(5)
Background and aim The increasing number of coronary artery bypass grafting (CABG) is associated with a need for active introduction of methods improving immediate and long-term results of these interventions. Results of a number of studies conducted